PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 82 filers reported holding PMV PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $20,352,000 | -16.5% | 1,710,265 | 0.0% | 0.43% | -33.2% |
Q2 2022 | $24,371,000 | -31.6% | 1,710,265 | 0.0% | 0.65% | -16.3% |
Q1 2022 | $35,608,000 | -9.9% | 1,710,265 | 0.0% | 0.78% | +11.5% |
Q4 2021 | $39,507,000 | -22.5% | 1,710,265 | 0.0% | 0.70% | -1.3% |
Q3 2021 | $50,966,000 | -12.8% | 1,710,265 | 0.0% | 0.71% | -24.7% |
Q2 2021 | $58,423,000 | +3.9% | 1,710,265 | 0.0% | 0.94% | +10.6% |
Q1 2021 | $56,251,000 | -46.5% | 1,710,265 | 0.0% | 0.85% | -42.4% |
Q4 2020 | $105,198,000 | +73.3% | 1,710,265 | 0.0% | 1.47% | +32.4% |
Q3 2020 | $60,714,000 | – | 1,710,265 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |